Linvoseltamab for treating relapsed or refractory multiple myeloma after 3 or more treatments [ID6609]

  • In development
  • GID-TA11052
  • Expected publication date: 

Documents

Documents created during the development process.

Committee meetings

  • Committee meeting: 1

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators